Results 101 to 110 of about 210,319 (212)

Cost-utility Analysis of Vertebroplasty versus Thoracolumbosacral Orthosis in the Treatment of Traumatic Vertebral Fractures [PDF]

, 2015
Purpose: To evaluate the cost-utility of Vertebroplasty versus conservative therapy (Thoracolumbosacral orthosis) for treatment of post-traumatic non-osteoporotic and/or non-neoplastic fractures.Materials and Methods: A prospective, randomized, non ...
Audibert, Martine, Chabert, Emmanuel, Mons, Antoine, Peirera, Bruno, Yakhelef, Nadia   +4 more
core   +1 more source

Cost-Effectiveness Study of Difamilast 1% for the Treatment of Atopic Dermatitis in Adult Japanese Patients

Dermatology and Therapy
Introduction Difamilast has proven to be an effective treatment for the treatment of atopic dermatitis (AD) in Japan, but its cost-effectiveness remains unknown.
Takeshi Nakahara, Shinichi Noto, Miyuki Matsukawa, Hiroe Takeda, Yilong Zhang, Tomohiro Kondo   +5 more
doaj   +1 more source

Cost-effectiveness analysis of CTZ/TAZ for the treatment of ventilated hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia in Japan

BMC Health Services Research
Background Resistant bacterial infections, particularly those caused by gram-negative pathogens, are associated with high mortality and economic burdens.
Risako Takaya, Nobuyoshi Mori, Eiko Saito, Sachiko Ohde   +3 more
doaj   +1 more source

Impact on the Incremental Cost-Effectiveness Ratio of Using Alternatives to EQ-5D in a Markov Model for Multiple Sclerosis. [PDF]

Pharmacoeconomics, 2016
Versteegh M.
europepmc   +1 more source

What does it take for an R&D tax incentive policy to be effective? [PDF]

While in 1996, 12 OECD countries offered R&D tax incentives, in 2008 this number increased to 21. Most countries have opted for level-based instead of incremental R&D tax incentives.
Lokshin, Boris, Mohnen, Pierre
core  

PRM35 - INCREMENTAL COST EFFECTIVENESS RATIO (ICER) THRESHOLD, THE END OF HORIZONTAL EQUITY? [PDF]

Value in Health, 2018
E Clay, S Aballea, C François, M Toumi
openaire   +1 more source

Economic Evaluation of Positron Emission Tomography (PET) in Non Small Cell Lung Cancer (NSCLC), CHERE Working Paper 2007/6 [PDF]

Background: There are several perceived benefits from introducing positron emission tomography (PET) scanning into the staging of non small lung cancer (NSCLC).
Alex Bird, Richard Norman, Stephen Goodall   +2 more
core  

PRM6 DEVELOPMENT OF AN INCREMENTAL COST-EFFECTIVENESS RATIO WITH SOME EQUITY IMPLICATION [PDF]

Value in Health, 2011
Wang, J.D., Hung, M.C.
openaire   +1 more source

Cost-effectiveness of implantable cardioverter-defibrillators for primary prevention in heart failure with reduced ejection fraction: a Markov model using JROAD-DPC cost data in Japan. [PDF]

Front Cardiovasc Med
Ohashi K, Watanabe M, Morii Y, Yokoshiki H, Kusano K, Imai K, Takagi M, Yamane T, Tada H, Ogasawara K.   +9 more
europepmc   +1 more source

Multiple Decision Criteria for Assessing An Incremental Cost-Effectiveness Ratio of Expensive Health Technologies [PDF]

Value in Health, 2014
Kamae, I., Yamabe, K., Sugimoto, T
openaire   +2 more sources